Document Type : Research articles


Department of General Surgery, Tepecik Training and Research Hospital, University of Health Sciences, Izmir, Turkey


Background: The employment of oncoplastic techniques for the treatment of central breast cancer is becoming increasingly popular.
Objectives: Our study aimed to evaluate the oncological safety of oncoplastic techniques in central breast cancer patients, and to assess resulting breast aesthetics and patient satisfaction.
Methods: This descriptive study examined 68 patients with central breast cancer who were operated consecutively between March 2017 and March 2020. Demographic characteristics of the patients, biological characteristics of the tumor, surgical techniques and adjuvant treatments, postoperative complications, and follow-up (oncological, aesthetic, and satisfaction) results were evaluated.
Results: Sixty-eight patients were monitored for an average of 25 months post-operatively. Re-excision was required in 2 (2.9%) cases because of positive surgical margins. Local recurrence ensued in a total of 2 (2.9%) cases, and overall survival was 100%. During the postoperative follow-up period, an independent panel scored breast aesthetics at 76/100, while the patient satisfaction score was obtained at 7.5 on a 9-point Likert-type scale. Complications developed in 10 (14.7%) cases in our series.
Conclusion: According to our study findings, oncoplastic techniques can be considered safe in terms of oncological results for the surgical treatment of central breast cancer. This approach may provide high patient satisfaction.


  1. Kaufman CS. Increasing role of oncoplastic surgery for breast cancer. Curr Oncol Rep. 2019 ;21(12):111. doi :10.1007/s11
  2. -019-0860-9. [PubMed: 31838584].
  3. Losken A, Dugal CS, Styblo TM, Carlson GW. A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique. Ann Plast Surg. 2014 ;72(2):145–9. doi:10.1097/sap.0b013e3182605598. [PubMed: 23503430].
  4. De La Cruz L, Blankenship SA, Chatterjee A, Geha R, Nocera N,
  5. Czerniecki BJ, et al. Outcomes after oncoplastic breast-conserving surgery in breast cancer patients: a systematic literature review. Ann Surg Oncol. 2016;23(10):3247–58. doi: 10.1245/s10434-016-5313-1. [PubMed: 27357177].
  6. Haffty BG, Wilson LD, Smith R, Fischer D, Beinfield M, Ward B, et al. Subareolar breast cancer: long-term results with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33(1):53–7. doi:10.1016/0360-3016(95)001
  7. -U. [PubMed: 7642431].
  8. Shen YF, Huang J, Zhou WB, Li JH, Xiao Z, Huang AJ, et al. Breast-conserving in centrally located breast cancer patients confirmed safe by SEER based study. Gland Surg. 2022;11(1):226–35. doi: 10.21037/gs-21-914. [PubMed: 35242684].
  9. McCulley SJ, Durani P, Macmillan RD. Therapeutic mammaplasty for centrally located breast tumors. Plast Reconstr Surg. 2006;117(2):366–73. doi: 10.1097/01.prs.0000200874. 31320.c2. [PubMed: 16462314].
  10. Johnson M, Cook L, Rapisarda FI, Betal D, Bonomi R. Oncoplastic breast surgery technique for retroareolar breast cancer: a technical modification of the Grisotti flap in patients with short nipple to inferior mammary crease distance. J Surg Case Rep. 2020; 2020(9): 285. doi: 10.1093/jscr/rjaa285. [PubMed: 32934787].
  11. Huemer GM, Schrenk P, Moser F, Wagner E, Wayand W. Oncoplastic techniques allow breast-conserving treatment in centrally located breast cancers. Plast Reconstr Surg. 2007;120(2):390–8. doi: 10.1097/01.prs.0000267328.09
  12. 02. [PubMed: 17632339].
  13. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975;36(1):1–85. doi: 10.1002/1097-0142(197507)36:1%
  14.;2-4. [PubMed: 173455].
  15. Park HC, Kim HY, Kim MC, Lee JW, Chung HY, Cho BC, et al. Partial breast reconstruction using various oncoplastic techniques for centrally located breast cancer. Arch Plast Surg . 2014;41(5):520–8. doi: 10.5999/aps.2014.41.5.520. [PubMed: 25276644].
  16. Cardoso MJ, Cardoso JS, Vrieling C, Macmillan D, Rainsbury D, Heil J, et al. Recommendations for the aesthetic evaluation of breast cancer conservative treatment. Breast Cancer Res Treat. 2012;135(3):629–37. doi: 10.1007/s10549-012-1978-8. [Pub
  17. Med: 22307267].
  18. Shechter S, Friedman O, Inbal A, Arad E, Menes T, Barsuk D, et al. Oncoplastic partial breast reconstruction improves patient satisfaction and aesthetic outcome for central breast tumours. ANZ J Surg. 2019;89(5):536–40. doi: 10.1111/ans.15078. [Pub
  19. Med: 30895710].
  20. Adimulam G, Challa VR, Dhar A, Chumber S, Seenu V, Srivastava A. Assessment of cosmetic outcome of oncoplastic breast conservation surgery in women with early breast cancer: a prospective cohort study. Indian J Cancer. 2014;51(1):58–62. doi: 10.4103/0019-509x.134629. [PubMed: 24947098].
  21. Emiroglu M, Salimoglu S, Karaali C, Sert I, Gungor O, Sert F, et al. Oncoplastic reduction mammoplasty for breast cancer in women with macromastia: Oncological long-term outcomes. Asian J Surg. 2017;40(1):41–7. doi: 10.1016/j.asjsur.2015.07.
  22. [PubMed: 26358362].
  23. Gulcelik MA, Dogan L, Camlibel M, Karaman N, Kuru B, Alagol H, et al. Early complications of a reduction mammoplasty technique in the treatment of macromastia with or without breast cancer. Clin Breast Cancer. 2011;11(6):395–9. doi: 10.1016/j.clbc.2011.08.001. [PubMed: 21993009].
  24. Emiroglu M, Sert I, Karaali C, Aksoy SO, Ugurlu L, Aydın C. The effectiveness of simultaneous oncoplastic breast surgery in patients with locally advanced breast cancer. Breast Cancer. 2016;23(3):463–70. doi: 10.1007/s12282-015-0585-z. [PubMed: 25585655].